Skip to main content
Fig. 6 | Stem Cell Research & Therapy

Fig. 6

From: Scintigraphic tracking of 99mTechnetium-labelled equine peripheral blood-derived mesenchymal stem cells after intravenous, intramuscular, and subcutaneous injection in healthy dogs

Fig. 6

Measured radioactivity following intravenous intramuscular and subcutaneous injection of the radiolabelled ePB-MSCs. Following intravenous administration of ePB-MSCs labelled with 99mTc, the heart, lung, liver, spleen, kidneys and urinary bladder can be seen. Following intramuscular injection of the ePB-MSCs radiolabelled with 99mTc, the liver and kidneys can be seen. The injection site in the quadriceps muscle is clearly visible until the end of the evaluation period. Following subcutaneous injection of the ePB-MSCs radiolabelled with 99mTc, the liver, kidneys and bladder can be seen. The injection site in the neck is clearly visible until the end of the evaluation period. IV, intravenous (normal dose, IV; higher dose, IV+); IM, intramuscular; SC, subcutaneous

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512